NIH-funded research Fellowship grant

Understanding how Tet1 affects intestinal stem cells

Official title: Determining the role of Tet1 in facultative intestinal stem cells

Funded at Emory University · NIH-11057710 · Data updated 2026-11-12

This study is looking at how a protein called Tet1 helps the stem cells in your intestines heal after they get hurt, especially from treatments like chemotherapy, to find better ways to support recovery for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31DK136254-03
Project IDNIH-11057710 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who have undergone chemotherapy or radiation therapy and are experiencing intestinal damage.

Less likely to help

Patients who have not received cancer treatment or do not have intestinal health issues may not benefit from this research.

What this research studies

This research investigates the role of Tet1, a protein involved in gene regulation, in the behavior of intestinal stem cells that help maintain the health of the intestinal lining. It focuses on how these stem cells can regenerate after injury, which is often caused by cancer treatments like chemotherapy. By examining the genetic mechanisms behind this regeneration, the research aims to uncover how to better support the healing process in patients who have experienced damage to their intestinal cells. The study employs advanced techniques to analyze gene expression and cellular changes in response to injury.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments that enhance the recovery of intestinal health in cancer patients.

How similar studies have gone: Previous research has shown promising results in understanding the role of genetic factors in stem cell regeneration, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Janto, Nicolas Vaughan — Emory University
  • Study coordinator: Janto, Nicolas Vaughan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.